07/30/2025
7:03 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:50 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
3:50 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
07/01/2025
5:16 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
4:50 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Vantage II GP, L.P. (Reporting)
Versant Vantage II GP-GP, LLC (Reporting)
Versant Vantage II, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:49 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
06/11/2025
6:43 PM | Kolchinsky Peter (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:45 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Scheiner Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | Guerard Frederic (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LENZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/11/2025
4:46 PM | Drapkin Kimberlee C (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:46 PM | George Jeffrey P. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
3:19 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
05/07/2025
3:16 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
3:36 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form ARS | |
04/28/2025
3:30 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
3:33 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form DEFA14A | |
04/15/2025
7:37 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/14/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/09/2025
6:20 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:05 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
04/09/2025
3:06 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
04/08/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/08/2025
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/04/2025
3:45 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form POS AM | |
04/04/2025
3:46 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form POS AM | |
04/04/2025
3:48 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/04/2025
3:53 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/19/2025
3:45 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/19/2025
3:38 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
5:10 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:26 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:20 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:22 PM | Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:24 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
6:55 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:08 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
11/06/2024
7:03 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
11/06/2024
7:06 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
11/06/2024
6:35 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:26 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
7:23 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
7:24 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
7:09 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
09/19/2024
4:04 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
09/11/2024
3:09 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/14/2024
3:25 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
08/12/2024
7:05 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:11 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
